Search results for "Protective Agent"

showing 10 items of 226 documents

Efficacy and tolerability of a fixed dose combination of cortex phospholipid liposomes and cyanocobalamin for intramuscular use in peripheral neuropa…

2019

Peripheral neuropathies are frequently encourtered in clinical practice and are assiociated with a major impairment in quality of life . Howewvwr, their management reamans poor, and current therapies are often burdened with major side effects and can present poor efficacy on pain and functionality. Therefore, it has been suggested that the combination of two or more different drugs may improve analgesis efficacy and reduce side effects. Tricortin 1000 is formulated with 12 mg of Brain cortex phospholipid liposomes + 1000 microgrammi of Cyanocobalamin injectable (PL+ CNCb1) for intramuscolar use and is indicated in the tratment of poly-algo-neuropathic syndromes. This combination exerts a ma…

Viitamin B 12Fixed-dose combinationAnalgesicPharmacologyInjections IntramuscularInjections03 medical and health sciences0302 clinical medicinePharmacotherapyPeripheral nervous system diseasemedicineHumansCyanocobalaminphospholipidPhospholipidsCerebral CortexIntramuscularAnalgesicsClinical Trials as TopicNeck painLiposomebiologybusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaBack painPeripheral Nervous System DiseasesGeneral MedicineBack pain; Liposomes; Neuralgia; Peripheral nervous system diseases; Phospholipids; Vitamin B 12; Analgesics; Cerebral Cortex; Clinical Trials as Topic; Drug Combinations; Humans; Injections Intramuscular; Liposomes; Neuroprotective Agents; Peripheral Nervous System Diseases; Phospholipids; Vitamin B 12Drug CombinationsVitamin B 12Neuroprotective AgentsTolerability030220 oncology & carcinogenesisLiposomesbiology.proteinNeuralgia030211 gastroenterology & hepatologyIiposomemedicine.symptombusinessNeurotrophinMinerva Medica
researchProduct

Erythropoietin: a new paradigm for neuroprotection.

2006

business.industryNeuroprotectionRecombinant ProteinsAnesthesiology and Pain MedicineNeuroprotective AgentsErythropoietinCentral Nervous System DiseasesBrain InjuriesReceptors ErythropoietinMedicineHumansSurgeryNeurology (clinical)businessNeuroscienceErythropoietinmedicine.drugJournal of neurosurgical anesthesiology
researchProduct

4-hydroxynonenal inhibits glutathione peroxidase: protection by glutathione

1999

Abstract 4-Hydroxy-2,3-trans-nonenal, a lipid peroxidation product, inhibits glutathione peroxidase in a concentration-dependent manner. The concentration providing 50% inhibition is 0.12 mM. This inhibition can be almost completely (89%) prevented by 1 mM glutathione added to the incubation mixture 30 min before 4-hydroxy-2,3-trans-nonenal or 2,3-trans-nonenal, but not by other thiol-containing antioxidants such as 0.5 mM dithiothreitol or β-mercaptoethanol. Again the addition of 1 mM glutathione, and not of 0.5 mM dithiothreitol or β-mercaptoethanol, to the enzyme 30 min after incubation with 4-hydroxy-2,3-trans-nonenal restores activity to the same extent as does the preincubation with G…

chemistry.chemical_classificationAldehydesGlutathione PeroxidaseGPX3Glutathione peroxidaseGlutathione reductaseGlutathioneGPX4GlutathioneBiochemistryDithiothreitol4-HydroxynonenalLipid peroxidationchemistry.chemical_compoundNeuroprotective AgentschemistryBiochemistryPhysiology (medical)HumansLipid PeroxidationEnzyme InhibitorsFree Radical Biology and Medicine
researchProduct

Therapeutic use of omega-3 fatty acids in bipolar disorder

2011

Bipolar disorder (BD) is a severe, chronic affective disorder, associated with significant disability, morbidity and premature mortality. Omega-3 polyunsaturated fatty acids (PUFAs) play several important roles in brain development and functioning. Evidence from animal models of dietary omega-3 (n-3) PUFA deficiency suggest that these fatty acids are relevant to promote brain development and to regulate behavioral and neurochemical aspects related to mood disorders, such as stress responses, depression and aggression, as well as dopaminergic content and function. Preclinical and clinical evidence suggests roles for PUFAs in BD. n-3 PUFAs seem to be an effective adjunctive treatment for unip…

chemistry.chemical_classificationBipolar Disordermedicine.drug_classBrain-Derived Neurotrophic FactorGeneral NeuroscienceDopaminergicMood stabilizerBioinformaticsmedicine.diseaseNeuroprotectionNeuroprotective AgentsNeurochemicalMood disorderschemistryFatty Acids Omega-3Adjunctive treatmentmedicineAnimalsHumansPharmacology (medical)Neurology (clinical)Bipolar disorderPsychologyClinical psychologyPolyunsaturated fatty acidExpert Review of Neurotherapeutics
researchProduct

Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.

2012

Full-length native rat amylin 1-37 has previously been widely shown to be unable to form fibrils and to lack the toxicity of the human amylin form leading to its use as a non-amyloidogenic control peptide. A recent study has suggested that rat amylin 1-37 forms amyloidogenic β-sheet structures in the presence of the human amylin form and suggested that this property could promote toxicity. Using TEM analysis we show here fibril formation by synthetic rat amylin 1-37 and 8-37 peptides when the lyophilized HPLC purified peptides are initially dissolved in 20 mM Tris-HCl. Dissolution of synthetic rat amylin 1-37 and 8-37 peptides in H(2)O or phosphate buffered saline failed to produce fibrils.…

endocrine systemAmyloidendocrine system diseasesAmyloidmedicine.drug_classGeneral Physics and AstronomyAmylinPeptideAmyloidogenic Proteinsmacromolecular substancesFibrilAmino Acid Chloromethyl Ketoneschemistry.chemical_compoundIslets of LangerhansMicroscopy Electron TransmissionStructural BiologymedicineAnimalsHumansGeneral Materials ScienceCells Culturedchemistry.chemical_classificationgeographygeography.geographical_feature_categoryCell BiologyIsletReceptor antagonistCatalasePeptide FragmentsCongo redIslet Amyloid PolypeptideRatsNeuroprotective AgentsBiochemistrychemistryCell cultureMicron (Oxford, England : 1993)
researchProduct

Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation.

2011

Phytoestrogens are a group of plant-derived compounds that include mainly isoflavones like daidzein. Phytoestrogens prevent neuronal damage and improve outcome in experimental stroke; however, the mechanisms of this neuroprotective action have not been fully elucidated. In this context, it has been postulated that phytoestrogens might activate the peroxisome proliferator-activated receptor-γ (PPARγ), which exerts neuroprotective effects in several settings. The aim of this study was to determine whether the phytoestrogen daidzein elicits beneficial actions in neuronal cells by mechanisms involving activation of PPARγ. Our results show that daidzein (0.05-5 μM) decreases cell death induced b…

endocrine systemmedicine.drug_classPyridinesPeroxisome proliferator-activated receptorPharmacologyLigandsNeuroprotectionCellular and Molecular Neurosciencechemistry.chemical_compoundmedicineSynaptic vesicle recyclingAnimalsReceptorCells Culturedchemistry.chemical_classificationNeuronsDaidzeinfood and beveragesCell BiologyIsoflavonesReceptor antagonistIsoflavonesRatsOxygenPPAR gammaGlucoseNeuroprotective AgentschemistryBenzamidesPhytoestrogensNeurochemistry international
researchProduct

Expression and regulation of mPer1 in immortalized GnRH neurons.

2003

Hypothalamic GnRH (gonadotropin-releasing hormone) neurons play a critical role in the initiation and maintenance of reproduction competence. Using the mouse GnRH neuronal cell line, GT1-7, we have characterized the expression of the gene mPer1, a recognized key element of the mammalian circadian clockwork. Both mPer1 transcripts and the 136 kDa mPER1 gene product could be detected in these cells. Immunocytochemical analysis also confirmed expression of mPER1 both in vitro and in vivo in GnRH neurons. Activation of cyclic AMP signalling pathways in vitro elevated GnRH secretion as well as mPer1 expression and nuclear mPER1 immunoreactivity. As mPER1 is known to feedback on transcriptional a…

endocrine systemmedicine.medical_specialtyCellImmunoblottingCell Cycle ProteinsBiologyGene productGonadotropin-Releasing HormoneMiceInternal medicineGene expressionmedicineAnimalsGeneCells CulturedRegulation of gene expressionNeuronsReverse Transcriptase Polymerase Chain ReactionGeneral NeuroscienceColforsinNuclear ProteinsPeriod Circadian ProteinsImmunohistochemistryPreoptic AreaIn vitromedicine.anatomical_structureEndocrinologyNeuroprotective AgentsGene Expression RegulationCell cultureHypothalamushormones hormone substitutes and hormone antagonistsVasoactive Intestinal PeptideNeuroreport
researchProduct

Transgenic Killer Commensal Bacteria as Mucosal Protectants

2001

As first line of defense against the majority of infections and primary site for their transmission, mucosal surfaces of the oral cavity and genitourinary, gastrointestinal, and respiratory tracts represent the most suitable sites to deliver protective agents for the prevention of infectious diseases. Mucosal protection is important not only for life threatening diseases but also for opportunistic infections which currently represent a serious burden in terms of morbidity, mortality, and cost of cures. Candida albicans is among the most prevalent causes of mucosal infections not only in immuno- compromised patients, such as HIV-infected subjects who are frequently affected by oral and esoph…

lcsh:Medicinemedicine.disease_causeEsophageal candidiasislcsh:TechnologyGeneral Biochemistry Genetics and Molecular BiologyMicrobiologymucosal immunotherapyCandida albicansmedicineAnimalsHumansTransgenesCandida albicanslcsh:ScienceKiller recombinant antibodiesAntibodies FungalGeneral Environmental ScienceMucous MembranebiologyGenitourinary systemTransmission (medicine)Streptococcuslcsh:Ttransgenic commensal bacterislcsh:RCandidiasisMucous membraneStreptococcusGeneral Medicinebiology.organism_classificationmedicine.diseasemedicine.anatomical_structureProtective AgentsToxicityImmunologyVaginalcsh:QFemaleDirections in ScienceThe Scientific World Journal
researchProduct

EndothelinA receptor antagonist BSF-208075 causes immune modulation and neuroprotection after stroke in gerbils.

2005

Leukocytes contribute to the ischemia-reperfusion injury. Recent studies suggested endothelins could be important mediators for leukocyte activation in stroke. We tested if the endothelinA receptor antagonist BSF-208075 (ambrisentan) could reduce an ischemic lesion by modulation of leukocyte-endothelium interactions. Twenty-four gerbils underwent either a sham operation (n=6) or 15 min of bilateral carotid artery occlusion resulting in global cerebral ischemia. Ischemic animals received normal saline (n=6), 5 mg/kg BSF-208075 (n=6) or 30 mg/kg (n=6) administered intravenously at 10 min of reperfusion. Leukocytes rolling or adhering to endothelium were counted by intravital microscopy in par…

medicine.hormoneMaleAmbrisentanmedicine.drug_classEndothelin A Receptor AntagonistsIschemiaPharmacologyBrain IschemiaEndothelinsLeukocytesMedicineAnimalsImmunologic FactorsMolecular BiologyStrokeDose-Response Relationship DrugPhenylpropionatesbusiness.industryGeneral NeuroscienceEndothelinsAntagonistBrainmedicine.diseaseReceptor antagonistReceptor Endothelin APyridazinesStrokeChemotaxis LeukocyteNeuroprotective AgentsTreatment OutcomeAnesthesiaCerebrovascular CirculationReperfusion InjuryNerve DegenerationEncephalitisNeurology (clinical)businessEndothelin receptorGerbillinaeIntravital microscopyDevelopmental Biologymedicine.drugBrain research
researchProduct

Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms.

2014

Postmenopausal women may be more vulnerable to cognitive loss and Alzheimer's disease (AD) than premenopausal women because of their deficiency in estrogens, in addition to their usually older age. Aerobic physical exercise has been proposed as a therapeutic approach for maintaining health and well-being in postmenopausal women, and for improving brain health and plasticity in populations at high risk for AD. To study the neuroprotective mechanisms of physical exercise in a postmenopausal animal model, we submitted previously ovariectomized, six-month old non-transgenic and 3xTg-AD mice to three months of voluntary exercise in a running wheel. At nine months of age, we observed lower grip s…

medicine.medical_specialtyBehavioral testsEndocrinology Diabetes and MetabolismOvariectomyP-CREBPhysical exerciseMice Transgenictau ProteinsCREBNeuroprotectionGrip strengthAmyloid beta-Protein PrecursorMiceEndocrinologyCognitionAlzheimer DiseaseInternal medicinePhysical Conditioning AnimalNeuroplasticitymedicinePresenilin-1DementiaAnimalsApathy3xTg-AD miceBiological PsychiatryNeuronsFrailtybiologyEndocrine and Autonomic SystemsBrain-Derived Neurotrophic FactorPhysical exerciseAlzheimer's diseaseCatalasemedicine.diseaseMice Inbred C57BLPsychiatry and Mental healthDisease Models AnimalBDNFEndocrinologyNeuroprotective AgentsCytoprotectionbiology.proteinOvariectomized ratFemalemedicine.symptomPsychologySignal TransductionPsychoneuroendocrinology
researchProduct